scispace - formally typeset
S

Solange Cavalcante

Researcher at Oswaldo Cruz Foundation

Publications -  62
Citations -  2755

Solange Cavalcante is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Tuberculosis & Population. The author has an hindex of 22, co-authored 55 publications receiving 2483 citations. Previous affiliations of Solange Cavalcante include Evandro Chagas Institute & Pontifical Catholic University of Rio de Janeiro.

Papers
More filters
Journal ArticleDOI

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Haileyesus Getahun, +71 more
TL;DR: The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation and patients with silicosis.
Journal ArticleDOI

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

TL;DR: The use of both IPT and ART in HIV-infected patients is associated with significantly reduced tuberculosis incidence, and in conjunction with expanded access to ART, the wider use of IPT in patients with HIV will improve tuberculosis control in high burden areas.
Journal ArticleDOI

Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection

TL;DR: This paper outlines challenges to implementation of preventive therapy and provides pragmatic suggestions for overcoming them and advocates for tuberculosis preventive therapy as the core of a renewed worldwide focus to implement a comprehensive epidemic control strategy that would reduce new tuberculosis cases to elimination targets.

How to eliminate tuberculosis 3 Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection

TL;DR: In this paper, the authors outline challenges to implementation of preventive therapy and provide pragmatic suggestions for overcoming them, and advocate for tuberculosis preventive therapy as the core of a renewed worldwide focus to implement a comprehensive epidemic control strategy that would reduce new tuberculosis cases to elimination targets.